City Therapeutics, Inc. CTY
18.67 USD +0.42 (+2.30%)
At closeNov 9, 2026, 5:41 PM EST
18.67 0.00 0.00%
After hours · Nov 9, 5:41 PM ET
17.88 Day range 18.85
15.81 52-week range 23.88
- YTD
- -16.65%
- 1 year
- -16.65%
News
globenewswire.com Phase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annual Meeting CAMBRIDGE, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (Nasdaq: CTY), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi)…
globenewswire.com City Therapeutics to Present at Upcoming November Investor Conferences CAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (Nasdaq: CTY), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi)…